Pharmafile Logo
Pharmafocus logo
Advanced Search

HLB’s liver cancer treatment awarded Orphan Drug Status by FDA

November 8, 2021
Sales and Marketing

HLB have announced that its anticancer drug candidate, rivoceranib, has been awarded Orphan Drug Status by the FDA. HLB is …

News

UK government to roll out Merck antiviral pill, Pfizer COVID pill cuts hospitalisations by 89%

November 8, 2021
Sales and Marketing

The UK government will roll out Merck’s COVID-19 antiviral pill, molnupiravir, through drug trial later this month. In early November, …

News

FDA decline Emergency Use Authorisation for ZYESAMI® in patients with critical COVID

November 5, 2021
Medical Communications

The FDA has declined to grant Emergency Use Authorisation for NRx Pharmaceuticals’ therapy, Zyesami® (aviptadil), in the treatment of critical …

News
credit_-_crevis_shutterstock_340710245_720

Pfizer and Entia’s breast cancer home test in final stages

November 5, 2021
Medical Communications

Pfizer UK and Entia’s home blood monitoring device for breast cancer patients is in late-stage development, with regulatory approvals expected …

News

Republicans governors retaliate against Biden vaccine mandate

November 5, 2021
Medical Communications

Republican governors are expected to sue in response to the Biden administration’s requirement that US employers ensure workers are tested …

News

Scientists identify new drug combination for children with brain cancer

November 5, 2021
Medical Communications

A new study has shown that combining two existing cancer drugs for leukaemia and melanoma could offer a promising future …

News

England COVID-19 prevalence rose to highest levels in October, study finds

November 4, 2021
Business Services

Imperial College London have said that COVID-19 rates in England rose to its highest level on record in October. This …

News

WHO grants emergency use listing to COVID vaccine

November 4, 2021
Business Services

WHO has approved Bharat Biotech’s Covaxin COVID-19 vaccine for emergency use in individuals aged 18 years and above. Two doses …

News

FDA fast track oral treatment of dermatitis

November 4, 2021
Business Services

UNION therapeutics have received a Fast Track designation from the FDA for their oral orismilast for the treatment of moderate …

News

HPV vaccine cutting cervical cancer rates by 87%

November 4, 2021
Business Services

The human papillomavirus (HPV) vaccine is cutting cervical cancer rates by 87% in women who were offered the vaccine between …

News
kjm_cropped

HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs

November 3, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HMNC Brain Health, appointments

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …

Appointment

Study reveals Alzheimer’s spreads differently than previously thought

November 3, 2021
Research and Development

A University of Cambridge research team has used human data to quantify the speed of different processes that lead to …

News

Clinical trial shows promise for aggressive eye cancer treatment

November 3, 2021
Research and Development

A clinical trial with University of Liverpool researchers at The Clatterbridge Cancer Centre has shown great promise for an immunotherapy …

News

Outsourcing in clinical trials: A response to rising challenges

November 3, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …

Feature

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

November 3, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …

Feature

Breakthrough status given to Renew Bioscience’s Alzheimer’s treatment

November 3, 2021
Research and Development

Renew Bioscience announced it has received Breakthrough Device Designation status from the FDA for the Cerezen® Device, a novel treatment …

News

Covid jabs more effective than virus at preventing infection

November 3, 2021
Research and Development

A US study has revealed that the immunity received from COVID-19 vaccines is much stronger than that stimulated by infection …

News
beverley-carr-enhanced

Beverley Carr appointed Chief Business Officer for Amphista Therapeutics

November 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …

Appointment

Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor

November 2, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, mogrify

Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …

Appointment

BioNet and BIA Separations collaborate on development of mRNA vaccines

November 2, 2021
Manufacturing and Production

BioNet, a leading biotech company manufacturing genetically engineered vaccines, and Sartorius’ company BIA Separations, have announced the development of an …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026